Altimmune Inc (ALT)
7.30
+0.11
(+1.53%)
USD |
NASDAQ |
May 03, 16:00
7.34
+0.04
(+0.55%)
After-Hours: 20:00
Altimmune Shareholders Equity (Quarterly): 194.10M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 194.10M |
September 30, 2023 | 150.40M |
June 30, 2023 | 167.71M |
March 31, 2023 | 167.73M |
December 31, 2022 | 185.29M |
September 30, 2022 | 205.03M |
June 30, 2022 | 194.54M |
March 31, 2022 | 184.87M |
December 31, 2021 | 199.14M |
September 30, 2021 | 209.26M |
June 30, 2021 | 241.28M |
March 31, 2021 | 246.44M |
December 31, 2020 | 225.88M |
September 30, 2020 | 199.71M |
June 30, 2020 | 79.52M |
March 31, 2020 | 41.90M |
December 31, 2019 | 45.52M |
September 30, 2019 | 49.38M |
June 30, 2019 | 56.22M |
March 31, 2019 | 59.32M |
December 31, 2018 | 48.31M |
September 30, 2018 | 39.68M |
June 30, 2018 | 36.32M |
March 31, 2018 | 46.49M |
December 31, 2017 | 48.68M |
Date | Value |
---|---|
September 30, 2017 | 57.07M |
June 30, 2017 | 75.98M |
March 31, 2017 | 18.05M |
December 31, 2016 | 32.21M |
September 30, 2016 | 136.38M |
June 30, 2016 | 24.25M |
March 31, 2016 | 15.63M |
December 31, 2015 | 16.65M |
September 30, 2015 | 17.67M |
June 30, 2015 | 18.34M |
March 31, 2015 | 20.02M |
December 31, 2014 | 18.27M |
September 30, 2014 | 18.11M |
June 30, 2014 | 10.86M |
March 31, 2014 | 8.325M |
December 31, 2013 | 7.336M |
September 30, 2013 | 11.35M |
June 30, 2013 | 13.22M |
March 31, 2013 | 9.943M |
December 31, 2012 | 11.67M |
September 30, 2012 | 12.55M |
June 30, 2012 | 13.55M |
March 31, 2012 | 13.77M |
December 31, 2011 | 15.85M |
September 30, 2011 | 14.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
41.90M
Minimum
Mar 2020
246.44M
Maximum
Mar 2021
160.21M
Average
185.29M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 12.81B |
Amgen Inc | 5.022B |
Pfizer Inc | 89.01B |
Viking Therapeutics Inc | 933.89M |
Precision BioSciences Inc | 18.86M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 210.64M |
Total Liabilities (Quarterly) | 16.54M |
Current Ratio | 17.26 |